Synthesis and structure-activity relationships of novel naphthalenic and bioisosteric related amidic derivatives as melatonin receptor ligands. 1994

P Depreux, and D Lesieur, and H A Mansour, and P Morgan, and H E Howell, and P Renard, and D H Caignard, and B Pfeiffer, and P Delagrange, and B Guardiola
Institut de Chimie Pharmaceutique, Lille, France.

A series of N-naphthylethyl amide derivatives were synthesized and evaluated as melatonin receptor ligands. The affinity of each compound for the melatonin receptor was determined by binding studies using [2-125I]iodomelatonin on ovine pars tuberalis membrane homogenates. Structure-activity relationships led to the conclusion that naphthalene is a bioisostere of the indole moiety of melatonin. Moreover it appears that the affinity is strongly affected by the size of the substituent of the nitrogen of the amidic function. Many of these ligands give biphasic dose-response curves which suggests that there may be two melatonin receptor subtypes within the ovine pars tuberalis cells. The replacement of naphthalene by benzofuran or benzothiophene did not strongly alter the affinity for the melatonin receptor. In contrast, the benzimidazole analogue was a poor ligand. Compound 7, the naphthalenic analogue of melatonin, a selective ligand of the melatonin receptor and an agonist derivative, has been selected for clinical development.

UI MeSH Term Description Entries
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008550 Melatonin A biogenic amine that is found in animals and plants. In mammals, melatonin is produced by the PINEAL GLAND. Its secretion increases in darkness and decreases during exposure to light. Melatonin is implicated in the regulation of SLEEP, mood, and REPRODUCTION. Melatonin is also an effective antioxidant.
D010903 Pituitary Gland, Anterior The anterior glandular lobe of the pituitary gland, also known as the adenohypophysis. It secretes the ADENOHYPOPHYSEAL HORMONES that regulate vital functions such as GROWTH; METABOLISM; and REPRODUCTION. Adenohypophysis,Anterior Lobe of Pituitary,Anterior Pituitary Gland,Lobus Anterior,Pars Distalis of Pituitary,Adenohypophyses,Anterior Pituitary Glands,Anterior, Lobus,Anteriors, Lobus,Lobus Anteriors,Pituitary Anterior Lobe,Pituitary Glands, Anterior,Pituitary Pars Distalis
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D005576 Colforsin Potent activator of the adenylate cyclase system and the biosynthesis of cyclic AMP. From the plant COLEUS FORSKOHLII. Has antihypertensive, positive inotropic, platelet aggregation inhibitory, and smooth muscle relaxant activities; also lowers intraocular pressure and promotes release of hormones from the pituitary gland. Coleonol,Forskolin,N,N-Dimethyl-beta-alanine-5-(acetyloxy)-3-ethenyldodecahydro-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-1H-naphtho(2,1-b)pyran-6-yl Ester HCl,NKH 477,NKH-477,NKH477
D000081 Acetamides Derivatives of acetamide that are used as solvents, as mild irritants, and in organic synthesis.
D000242 Cyclic AMP An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. Adenosine Cyclic 3',5'-Monophosphate,Adenosine Cyclic 3,5 Monophosphate,Adenosine Cyclic Monophosphate,Adenosine Cyclic-3',5'-Monophosphate,Cyclic AMP, (R)-Isomer,Cyclic AMP, Disodium Salt,Cyclic AMP, Monoammonium Salt,Cyclic AMP, Monopotassium Salt,Cyclic AMP, Monosodium Salt,Cyclic AMP, Sodium Salt,3',5'-Monophosphate, Adenosine Cyclic,AMP, Cyclic,Adenosine Cyclic 3',5' Monophosphate,Cyclic 3',5'-Monophosphate, Adenosine,Cyclic Monophosphate, Adenosine,Cyclic-3',5'-Monophosphate, Adenosine,Monophosphate, Adenosine Cyclic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

P Depreux, and D Lesieur, and H A Mansour, and P Morgan, and H E Howell, and P Renard, and D H Caignard, and B Pfeiffer, and P Delagrange, and B Guardiola
June 2002, Journal of medicinal chemistry,
P Depreux, and D Lesieur, and H A Mansour, and P Morgan, and H E Howell, and P Renard, and D H Caignard, and B Pfeiffer, and P Delagrange, and B Guardiola
May 2011, European journal of medicinal chemistry,
P Depreux, and D Lesieur, and H A Mansour, and P Morgan, and H E Howell, and P Renard, and D H Caignard, and B Pfeiffer, and P Delagrange, and B Guardiola
April 1992, Journal of medicinal chemistry,
P Depreux, and D Lesieur, and H A Mansour, and P Morgan, and H E Howell, and P Renard, and D H Caignard, and B Pfeiffer, and P Delagrange, and B Guardiola
October 2015, Chemical biology & drug design,
P Depreux, and D Lesieur, and H A Mansour, and P Morgan, and H E Howell, and P Renard, and D H Caignard, and B Pfeiffer, and P Delagrange, and B Guardiola
July 2004, Bioorganic & medicinal chemistry letters,
P Depreux, and D Lesieur, and H A Mansour, and P Morgan, and H E Howell, and P Renard, and D H Caignard, and B Pfeiffer, and P Delagrange, and B Guardiola
January 2004, Bioorganic & medicinal chemistry,
P Depreux, and D Lesieur, and H A Mansour, and P Morgan, and H E Howell, and P Renard, and D H Caignard, and B Pfeiffer, and P Delagrange, and B Guardiola
January 2013, Bioorganic & medicinal chemistry,
P Depreux, and D Lesieur, and H A Mansour, and P Morgan, and H E Howell, and P Renard, and D H Caignard, and B Pfeiffer, and P Delagrange, and B Guardiola
November 2014, Archiv der Pharmazie,
P Depreux, and D Lesieur, and H A Mansour, and P Morgan, and H E Howell, and P Renard, and D H Caignard, and B Pfeiffer, and P Delagrange, and B Guardiola
November 2002, Bioorganic & medicinal chemistry letters,
P Depreux, and D Lesieur, and H A Mansour, and P Morgan, and H E Howell, and P Renard, and D H Caignard, and B Pfeiffer, and P Delagrange, and B Guardiola
May 2010, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!